A Setback for MDMA-Assisted Psychotherapy
An FDA advisory committee concluded that MDMA's benefits had not been shown to outweigh its risks.
(Illustration: Joanna Andreasson)
Subscribe Now
This article is currently available to Reason Plus subscribers only. If you are a Reason Plus subscriber, log in here. Or subscribe to Reason Plus now.
Your Reason Plus subscription gives you instant access to brand new Reason magazine content and 50 years of Reason magazine archives.